Literature DB >> 6260872

Modification by adoptive humoral immunity of murine cytomegalovirus infection.

J D Shanley, M C Jordan, J G Stevens.   

Abstract

The effects of specific antiviral antibody on several aspects of infection with murine cytomegalovirus (CMV) were examined. Administration of immune serum 24 hr before subcutaneous inoculation of 10(5) plaque-forming units of murine CMV prevented detectable viral replication in the tissues of 92% of animals. Protection was associated with the immune globulin fraction and not with normal serum or heterologous antiviral serum. However, the development of latent murine CMV infection was not prevented by prior administration of antibody since immunosuppression with antilymphocyte serum and cortisone 16 weeks later unmasked dormant virus in 17 of 20 animals. In normal animals murine CMV-immune serum administered six days after acute virus infection had been initiated did not influence the outcome; however, in immunosuppressed mice, virus dissemination during acute infection was substantially reduced by specific antibody. These results demonstrate a significant effect of humoral immunity on the course of experimental CMV infection.

Entities:  

Mesh:

Year:  1981        PMID: 6260872     DOI: 10.1093/infdis/143.2.231

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  30 in total

1.  Viral Persistence Induces Antibody Inflation without Altering Antibody Avidity.

Authors:  Suzanne P M Welten; Anke Redeker; René E M Toes; Ramon Arens
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

Review 2.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

Review 3.  Molecular biology and immunology of cytomegalovirus.

Authors:  P D Griffiths; J E Grundy
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

4.  Comparison of serological tests for the detection of antibody to natural and experimental murine cytomegalovirus.

Authors:  G Lussier; D Guénette; J P Descôteaux
Journal:  Can J Vet Res       Date:  1987-04       Impact factor: 1.310

5.  Evaluation of immunoglobulin G preparations for anti-cytomegalovirus antibodies with reference to neutralizing antibody in the presence of complement.

Authors:  Y Eizuru; I Ueno; Y Minamishima
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

Review 6.  Role of antibodies in confining cytomegalovirus after reactivation from latency: three decades' résumé.

Authors:  Astrid Krmpotić; Jürgen Podlech; Matthias J Reddehase; William J Britt; Stipan Jonjić
Journal:  Med Microbiol Immunol       Date:  2019-03-28       Impact factor: 3.402

7.  Cytomegalovirus infection in heart transplant recipients: preliminary results of a controlled trial of intravenous gamma globulin.

Authors:  J K Preiksaitis; S Rosno; L Rasmussen; T C Merigan
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

8.  Detection of antibody to murine cytomegalovirus by enzyme-linked immunosorbent and indirect immunofluorescence assays.

Authors:  D C Classen; J M Morningstar; J D Shanley
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

9.  Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus.

Authors:  C A Stoddart; R D Cardin; J M Boname; W C Manning; G B Abenes; E S Mocarski
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

10.  Use of intravenous immune globulin in patients receiving bone marrow transplants.

Authors:  D J Winston; W G Ho; L E Rasmussen; C H Lin; H L Chu; T C Merigan; R P Gale
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.